China’s cellular agriculture company, Jimi Biotech, has developed the world’s first deer antler stem cell line, making Jimi Biotech the first company globally capable of mass-producing deer antler stem cells through cellular cultivation. This spontaneously immortalized cell line has undergone over 60 passages with a doubling time of under 24 hours. Deer antlers hold significant cultural and dietary importance in China and other Asian countries, where they are revered as a premium health products.
The market for deer antlers in China alone exceeds 3 billion RMB. The uniqueness of deer antlers lies in their ability to undergo complete regeneration periodically under natural conditions, prompting extensive research into their anti-aging and health benefits, especially pertaining to antler stem cells, which constitute less than 1% of the entire antler structure.
The cells used by Jimi Biotech were derived from the tip of the first two-bar antler of a three-year-old Sika deer. Prime-aged deer are said to have the best-quality antlers, while regeneration is believed to be strongest at the tips. Jimi Biotech is expected to submit a regulatory approval filing for its first cultivated deer antler products in 2024.
©Jimi Biotech
Jimi Biotech has successfully adapted its own cell lines to grow in suspension at more than 10 million cells per milliliter, and the cost of serum-free media has been reduced to 50 RMB (less than 7 USD) per liter. Previously, Jimi Biotech has developed China’s first beef cell line and first cultivated beef, but it will prioritize submitting the approval filing for deer antler products next year.